CTD
Asset Logo

Corporate Travel Management Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿจ HOTELS, RESTAURANTS & LEISURE

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ฐ Dividends

๐Ÿ’ต Cost

๐Ÿƒ Esg

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-7.11%
Annual Growth

5 years average annual growth

๐Ÿ’ฐ

2.46%
Annual dividend yield

Based on the most recent dividend

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

85
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Corporate Travel Management Ltd. engages in managing the procurement and delivery of travel and accommodation agency services for its clients. The company is headquartered in Brisbane, Queensland and currently employs 3,192 full-time employees. The company went IPO on 2010-12-15. The principal activities of the Company, consists of managing the procurement and delivery of travel and accommodation agency services for its clients. The Companyโ€™s segments include Australia and New Zealand, North America, Asia, and Europe. Its services include global corporate travel, and global meetings and events management. The firm designs global travel programs that design services and solutions for global business travel. The firm's technology framework enables it to integrate a range of tools into one travel portal, providing its global customers with a single, customized and configurable platform that meets the needs of user for maximum adoption, compliance and user-experience. The firm's specialist meetings and events division, Event Travel Management (ETM), consolidates its meetings and events expenditure.

๐Ÿ“ˆ Performance

Price History

+42.88%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ฐ Dividends

Payouts

๐Ÿ’ฐ Annual Dividend Yield*

2.46%

๐Ÿ’ฐ Annual Dividend Earnings Per $1,000 invested**

$24.60

๐Ÿ’ฐ Most Recent Dividend Franked Percentage Estimate

0.00%

๐Ÿ’ฐ Average Dividend Franked Percentage Estimate

86.36 %

๐Ÿ’ฐ Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Estimate your dividend

If you held

$

of CTD, your last dividend payment(s) would have been:

$ 102.92

on Fri Oct 04 2024

$ 107.32

on Fri Apr 05 2024

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2024

$0.29

0.00%

2023

$0.28

0.00%

2022

$0.05

NaN%

2021

$0.00

0.00%

2020

$0.18

NaN%

2019

$0.40

50.00%

2018

$0.36

100.00%

2017

$0.30

100.00%

2016

$0.24

100.00%

2015

$0.16

50.00%

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿƒ Environmental, Social and Governance scores โ„น๏ธ

๐ŸŒณ

Environmental Score
55

A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution

๐Ÿ•Š๏ธ

Social Score
49

An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.

โš–๏ธ

Governance Score
72

An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$12.98

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in CTD

85

๐Ÿ“Š Total Capital Earnings

$18K

๐Ÿ”ƒ Average investment frequency

25 weeks

๐Ÿ’ต Average investment amount

$4,520

โฐ Last time a customer invested in CTD

13 days
CTD investor breakdown
๐Ÿ’ต Income of investors

More than 200k

10%

150k - 200k

9%

100k - 150k

23%

50k - 100k

27%

Less than 50k

27%
๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

25%

35 - 90

72%
๐Ÿ™‹ Legal gender of investors

Female

32%

Male

68%

Pearlers who invest in CTD also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

3.21%

๐Ÿ“Š Share price

$100.33 AUD

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

โ›ณ๏ธ DIVERSIFIED

๐Ÿงฑ MATERIALS

๐Ÿ’ธ FINANCIALS

Find Out More

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

๐Ÿ™Œ Performance (5Yr p.a)

20.00%

๐Ÿ“Š Share price

$62.69 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

Washington H. Soul Pattinson & Co. Ltd. engages in the ownership of shares, coal mining, distribution and retail of pharmaceutical products; and manufacture of building products. The company is headquartered in Sydney, New South Wales. Its segments include Strategic Investments Portfolio, Large Caps Portfolio, Private Equity Portfolio, Credit Portfolio, Emerging Companies Portfolio and Property Portfolio. The Strategic Investments Portfolio segment includes significant investments in uncorrelated listed companies where it generally has board representation. Large Caps Portfolio segment is an actively managed, Australian listed equities portfolio. The Private Equity Portfolio segment includes long-term investments in unlisted companies to support their future growth. The Credit Portfolio segment includes investments in corporate loans, bonds, and structured instruments. The Emerging Companies Portfolio segment includes investments in attractive, early stage and high growth companies that are listed, about to undertake an Initial Public Offering (IPO) or are at a pre-IPO stage. Property Portfolio segment comprises direct property investments.

๐Ÿ™Œ Performance (5Yr p.a)

11.15%

๐Ÿ“Š Share price

$34.06 AUD

๐Ÿ’ธ FINANCIALS

๐Ÿ“ˆ HIGH PRICE GROWTH

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

๐Ÿ™Œ Performance (5Yr p.a)

26.88%

๐Ÿ“Š Share price

$50.12 AUD

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿค– TECHNOLOGY

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 9,980 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. The Companyโ€™s segments include Sleep and Respiratory Care and SaaS. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care to improve patient outcomes.

๐Ÿ™Œ Performance (5Yr p.a)

12.73%

๐Ÿ“Š Share price

$36.81 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐ŸŒณ ENVIRONMENTAL

๐Ÿ•Š๏ธ SOCIALLY AWARE

๐Ÿฉบ HEALTH CARE

Want more shares? Try these...

Cryosite Ltd. engages in the provision of long-term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales and currently employs 25 full-time employees. The company went IPO on 2002-05-09. The firm manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Clinical trials and biological services logistics and Cord Blood and tissue storage. The Clinical trials and biological services logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological services and cell gene therapies depot services. Cord Blood and tissue storage segment provides storage of cord blood and tissue samples. Its facilities are purpose-built to store a range of biological materials, including Cell Banks (MCB, WCB), Mesenchymal Stromal Cell (MSC) Therapies, Tumour-Infiltrating Lymphocyte Therapies and others.

๐Ÿ™Œ Performance (5Yr p.a)

294.81%

๐Ÿ“Š Share price

$0.85 AUD

๐Ÿ”ญ LIFE SCIENCES TOOLS & SERVICES

Centaurus Metals Ltd. engages in the exploration of metals, gold, iron ore and other mineral resources. The company is headquartered in Perth, Western Australia. The firm is engaged in exploration and evaluation activities related to mineral resources in Brazil. Its projects include Jaguar Nickel Sulfide Project, Boi Novo Copper Gold Project and Jambreiro Iron Ore Project. The Jaguar Nickel Sulfide Project is located in the western portion of the Carajas Mineral Province of Brazil. The Jaguar Project includes multiple nickel sulfide deposits and exploration targets within an approximately 30 square kilometers (km2) land package. The Jaguar Project is located approximately 35 kilometers (km) north of the regional center of Tucuma. The Boi Novo Copper-Gold Project covers 35km2 of highly prospective ground in the eastern Carajas Mineral Province. The Companyโ€™s 100%-owned Jambreiro Project, located in south-east Brazil, is an advanced development opportunity for approximately three million tons per annum (Mtpa) of production.

๐Ÿ™Œ Performance (5Yr p.a)

17.22%

๐Ÿ“Š Share price

$0.34 AUD

โ›๏ธ MINING

๐Ÿ“ˆ HIGH PRICE GROWTH

CleanSpace Holdings Ltd. designs, manufactures and sells workplace respiratory protection equipment for healthcare and industrial end markets. The company is headquartered in Sydney, New South Wales. The company went IPO on 2020-10-23. The firm provides respiratory protection equipment for healthcare and industrial applications. The Companyโ€™s product offerings include CleanSpace HALO, CleanSpace2, CleanSpace ULTRA and CleanSpace EX. The firm provides a clinically designed powered air purifying respirator (PAPR) system, CleanSpace Halo, which is compatible with other personal protective equipment (PPE) and clinical head gear. CleanSpace2 is suitable for industries such as metal fabrication and welding; chemical or biological material handling; maintenance and cleaning; grain and food handling; high dust environments; mining and quarry; and stone, cement and concrete handling. Its subsidiaries include CleanSpace IP Pty Ltd, CleanSpace Technology Pty Limited, CleanSpace Americas, Inc, CleanSpace Technology Singapore Pte Ltd and CleanSpace NZ Ltd.

๐Ÿ“Š Share price

$0.44 AUD

๐Ÿฉบ HEALTH CARE

Constellation Technologies Ltd. specializes in Internet of Things (IoT) product development and product management. The company is headquartered in Melbourne, Victoria. The firm is focused on offering solutions to market, which leverage cloud, IoT, edge-computing sensors, big data, analytics, machine learning (ML), artificial intelligence (AI) and other advanced technologies. The firm through Callisto offers a range of solutions designed to address various industry needs. These solutions include Food Safety & Compliance, Drugs & Medicine Monitoring, Cold Chain Logistics, and Asset Management. Its Gen3 IoT product line offers IoT devices that can capture critical data points across a range of applications, providing its customers with reliable and flexible solutions that support multiple communication networks and sensor customization. Its MeridianCT is a cloud-based software platform and mobile application, which enables users to have an end-to-end IoT data solution to connect, monitor and visualize their data.

๐Ÿ™Œ Performance (5Yr p.a)

-18.46%

๐Ÿ“Š Share price

$0.00 AUD

๐Ÿ”จ COMMERCIAL SERVICES & SUPPLIES

Compare
Add to watchlist